RACHEL BAISDEN: Open Payments
NPI 1780649087 · WILLIAMSON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 19 payments from 8 companies in 2025. Trend: 2023 $162 · 2024 $231 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $108 |
| Novo Nordisk Inc | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Abbott Laboratories | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: XIFAXAN, Ozempic, VRAYLAR, QULIPTA, UBRELVY, FREESTYLE LIBRE 2, Wegovy, Auvelity.
Industry payments across WV — which companies pay providers there.
